Business Wire
BusinessEli Lilly shares have held up better than the Dow over the past year, according to market-watchersThe Apex TimesBusinessEli Lilly credited with “major FDA win” for weight-loss drug in latest market reportThe Apex TimesBusinessCostco shopping picks and the market’s rate-hike watch: A Yahoo Finance “Go in the Know” roundupThe Apex TimesBusinessMarkets Tread Water as Jackson Hole Remarks Close; Microsoft Leads Tech Upward MoveThe Apex TimesBusinessBerkshire Hathaway closes $6.8 billion Taylor Morrison deal, deepening its homebuilding footprintThe Apex TimesBusinessWalmart to add Apple Pay and Google Pay to US checkout by end of 2026, narrowing gap in contactless paymentsThe Apex TimesBusinessPalantir’s “Rule of 40” jumps to 155%, pointing to faster growth and wider adjusted marginsThe Apex TimesBusinessNetflix’s Path Toward $100: Buybacks and a Bigger Ads Push Are Drawing Fresh AttentionThe Apex TimesBusinessJPMorgan taps David Fishman from Bank of America to lead North America technology M&A, Reuters reportsThe Apex TimesBusinessEli Lilly shares sit near $1,175, but a Yahoo Finance note points to relative performance as the case for the stockThe Apex TimesBusinessModerna and Merck report late-stage win for personalized melanoma vaccine with KeytrudaThe Apex TimesBusinessMicrosoft shares flash a fresh buy announcement after a breakout, reinforcing Wall Street’s AI focusThe Apex TimesBusinessEli Lilly shares have held up better than the Dow over the past year, according to market-watchersThe Apex TimesBusinessEli Lilly credited with “major FDA win” for weight-loss drug in latest market reportThe Apex TimesBusinessCostco shopping picks and the market’s rate-hike watch: A Yahoo Finance “Go in the Know” roundupThe Apex TimesBusinessMarkets Tread Water as Jackson Hole Remarks Close; Microsoft Leads Tech Upward MoveThe Apex TimesBusinessBerkshire Hathaway closes $6.8 billion Taylor Morrison deal, deepening its homebuilding footprintThe Apex TimesBusinessWalmart to add Apple Pay and Google Pay to US checkout by end of 2026, narrowing gap in contactless paymentsThe Apex TimesBusinessPalantir’s “Rule of 40” jumps to 155%, pointing to faster growth and wider adjusted marginsThe Apex TimesBusinessNetflix’s Path Toward $100: Buybacks and a Bigger Ads Push Are Drawing Fresh AttentionThe Apex TimesBusinessJPMorgan taps David Fishman from Bank of America to lead North America technology M&A, Reuters reportsThe Apex TimesBusinessEli Lilly shares sit near $1,175, but a Yahoo Finance note points to relative performance as the case for the stockThe Apex TimesBusinessModerna and Merck report late-stage win for personalized melanoma vaccine with KeytrudaThe Apex TimesBusinessMicrosoft shares flash a fresh buy announcement after a breakout, reinforcing Wall Street’s AI focusThe Apex TimesBusinessEli Lilly shares have held up better than the Dow over the past year, according to market-watchersThe Apex TimesBusinessEli Lilly credited with “major FDA win” for weight-loss drug in latest market reportThe Apex TimesBusinessCostco shopping picks and the market’s rate-hike watch: A Yahoo Finance “Go in the Know” roundupThe Apex TimesBusinessMarkets Tread Water as Jackson Hole Remarks Close; Microsoft Leads Tech Upward MoveThe Apex TimesBusinessBerkshire Hathaway closes $6.8 billion Taylor Morrison deal, deepening its homebuilding footprintThe Apex TimesBusinessWalmart to add Apple Pay and Google Pay to US checkout by end of 2026, narrowing gap in contactless paymentsThe Apex TimesBusinessPalantir’s “Rule of 40” jumps to 155%, pointing to faster growth and wider adjusted marginsThe Apex TimesBusinessNetflix’s Path Toward $100: Buybacks and a Bigger Ads Push Are Drawing Fresh AttentionThe Apex TimesBusinessJPMorgan taps David Fishman from Bank of America to lead North America technology M&A, Reuters reportsThe Apex TimesBusinessEli Lilly shares sit near $1,175, but a Yahoo Finance note points to relative performance as the case for the stockThe Apex TimesBusinessModerna and Merck report late-stage win for personalized melanoma vaccine with KeytrudaThe Apex TimesBusinessMicrosoft shares flash a fresh buy announcement after a breakout, reinforcing Wall Street’s AI focusThe Apex TimesBusinessEli Lilly shares have held up better than the Dow over the past year, according to market-watchersThe Apex TimesBusinessEli Lilly credited with “major FDA win” for weight-loss drug in latest market reportThe Apex TimesBusinessCostco shopping picks and the market’s rate-hike watch: A Yahoo Finance “Go in the Know” roundupThe Apex TimesBusinessMarkets Tread Water as Jackson Hole Remarks Close; Microsoft Leads Tech Upward MoveThe Apex TimesBusinessBerkshire Hathaway closes $6.8 billion Taylor Morrison deal, deepening its homebuilding footprintThe Apex TimesBusinessWalmart to add Apple Pay and Google Pay to US checkout by end of 2026, narrowing gap in contactless paymentsThe Apex TimesBusinessPalantir’s “Rule of 40” jumps to 155%, pointing to faster growth and wider adjusted marginsThe Apex TimesBusinessNetflix’s Path Toward $100: Buybacks and a Bigger Ads Push Are Drawing Fresh AttentionThe Apex TimesBusinessJPMorgan taps David Fishman from Bank of America to lead North America technology M&A, Reuters reportsThe Apex TimesBusinessEli Lilly shares sit near $1,175, but a Yahoo Finance note points to relative performance as the case for the stockThe Apex TimesBusinessModerna and Merck report late-stage win for personalized melanoma vaccine with KeytrudaThe Apex TimesBusinessMicrosoft shares flash a fresh buy announcement after a breakout, reinforcing Wall Street’s AI focusThe Apex Times
Back to front
Ulta taps exclusivity as Target’s Beauty Studio push pressures the beauty aisle
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 28, 11:47 AM EDT

Ulta taps exclusivity as Target’s Beauty Studio push pressures the beauty aisle

The specialty beauty retailer reported solid second-quarter results and lifted its outlook, but said makeup performance was close to flat year over year.

2 min readEditor-approved Apex article

Ulta Beauty is leaning harder into products and experiences it says are distinct as competition intensifies in mass retail, following a quarter in which results held up while makeup demand showed little acceleration.

In its recent update, Ulta reported strong second-quarter sales and raised its full-year guidance. While the company did not frame the quarter as a broad slowdown, the makeup category came in nearly flat versus the prior year, suggesting shoppers were still choosing essentials and replenishment rather than stepping up discretionary purchases.

The company’s strategy centers on exclusivity, a theme that matters in a market where beauty offerings are increasingly diversified across channels. In this cycle, Target has been promoting its Beauty Studio concept, effectively bringing more branded and category-curated beauty merchandising into a store format that has traditionally competed on price and convenience.

Ulta’s emphasis on exclusivity appears aimed at protecting traffic and conversion, especially for makeup shoppers. Exclusivity in retail usually means better access to certain brands, products, or curated assortments that customers cannot easily replicate elsewhere. For a specialty chain, those differentiators are intended to make it harder for shoppers to treat the category as interchangeable.

For consumers, the difference between “nearly flat” and growth in makeup can be meaningful. Makeup is typically more sensitive to changes in trends and promotional intensity, and a lack of year-over-year momentum can ripple into inventory decisions and marketing spend. Ulta’s commentary indicates it is aware of that pressure and is managing expectations while pointing to overall sales resilience.

Industry watchers will be looking for whether Ulta’s raised outlook reflects confidence that current demand conditions will last, or a near-term benefit from areas beyond makeup. In past cycles, beauty retailers often see performance diverge by category and by how promotions are structured. If makeup remains stuck, exclusivity efforts may need to translate into measurable gains, such as improved makeup sell-through or a broader uplift in companion categories.

Ulta also faces a broader retail reality: beauty is not only sold inside stores, but also marketed and purchased through digital channels. When mass retailers increase their beauty floor space and curated programming, they can compress differentiation unless specialty chains keep tightening their assortments, loyalty offers, and in-store experiences. Ulta’s “exclusivity” message suggests it is trying to maintain its role as the destination for beauty discovery rather than a substitute retailer.

Why It Matters

  • Ulta’s raised outlook indicates confidence in overall demand even as makeup appears to lag.
  • Nearly flat year-over-year makeup performance suggests category softness or intense competitive pressure at the margin.
  • Exclusivity is becoming a more central differentiator as mass retailers expand beauty merchandising.
  • The market will watch whether Ulta can convert “exclusivity” messaging into measurable category growth, not just headline sales.

Sources

Key Facts

  • Ulta Beauty reported strong second-quarter sales.
  • Ulta raised its full-year guidance following the second-quarter update.
  • The company said makeup comps were nearly flat year over year.
  • Ulta highlighted exclusivity amid competition tied to Target’s Beauty Studio initiative.

Retail & Consumer Related